Experimental Dermatology
Biosignatures of defective sebaceous gland activity in sebum‐rich and sebum‐poor skin areas in adult atopic dermatitis
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Biological agent exerts therapeutic effects by reversing abnormalities in amino acid metabolic pathways in psoriasis
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Clinical profile, treatment and quality of life of patients with psoriatic arthritis in Malaysia: A population‐based cross‐sectional study
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
The role of mast cells and related molecules in itch of hidradenitis suppurativa
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Analyses of tertiary lymphoid structures observed in cases of Merkel cell carcinoma showing spontaneous regression
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Cannabinoids for the treatment of autoimmune and inflammatory skin diseases: A systematic review
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Tissue fibrosis associated depletion of lipid‐filled cells
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
A retrospective analysis of 65 patients with acrodermatitis continua of Hallopeau
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Fucoidan suppresses proliferation and epithelial‐mesenchymal transition process via Wnt/β‐catenin signalling in hemangioma
Experimental Dermatology, Volume 33, Issue 3, March 2024.
Experimental Dermatology
Topical BCl‐2 inhibitor (ABT‐737) attenuates skin photoaging in mice
Experimental Dermatology, Volume 33, Issue 3, March 2024.